• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS21
Device Problem Positioning Failure (1158)
Patient Problem Insufficient Information (4580)
Event Date 10/17/2022
Event Type  Injury  
Event Description
On (b)(6) 2022, a perceval sutureless aortic heart valve pvs21 was attempted to be implanted through mics procedure.Reportedly, stj was quite narrow, and the visual field was poor.Thus, the lcc part of the perceval implanted in slightly higher position.As such, the valve was explanted and another pvs21 was opened and implanted.No further information is available at this time.
 
Manufacturer Narrative
Was not returned by site.
 
Manufacturer Narrative
Updated fields: b4, g3, g6, h2, h6.The manufacturing and material records for the perceval heart valve, model #icv1208, s/n # (b)(6) as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1208) perceval heart valve at the time of manufacture and release.Based on the information available, stj was quite narrow, the visual field was poor and the lcc part of the perceval implanted in slightly higher position.Furthermore, from the document review performed, no manufacturing deficiencies were identified.As such, the cause of the reported malpositioning event was reasonably attributed to patient anatomy.Should further information be received in the future, a follow up report will be submitted.
 
Event Description
The manufacturer was informed that on 17 oct 2022, a perceval sutureless aortic heart valve pvs21 was attempted to be implanted through mics procedure.Reportedly, stj was quite narrow, and the visual field was poor.Thus, the lcc part of the perceval implanted in slightly higher position.As such, the valve was explanted and another pvs21 was opened and implanted.Based on the further information received, no malfunction with the device was noted and the device was not considered as a contributary factor to the event.Reportedly, only 15 minutes was added to the procedure as a result of the reported event.There was no impact on the patient and patient was stable through the delay in the procedure.
 
Manufacturer Narrative
Updated fields: b4, b5, g3, g6, h2.Based on the information available, stj was quite narrow, the visual field was poor and the lcc part of the perceval implanted in slightly higher position.Reportedly, no malfunction with the device was noted and the device was not considered as a contributary factor to the event.Furthermore, from the document review performed, no manufacturing deficiencies were identified.As such, the cause of the reported malpositioning event was reasonably attributed to patient anatomy.Should further information be received in the future, a follow up report will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
roberta lamberti
5005 north fraser way
burnaby, bc 
MDR Report Key15794948
MDR Text Key303630304
Report Number3004478276-2022-00208
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/14/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVS21
Device Catalogue NumberICV1208
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/09/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-